Ginkgo Bioworks Holdings, Inc.
NYSE:DNABiotechnology
+$0.26 today
- Market cap
- $547.12M
- Beta
- 1.80
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$5.11
Volume 2.36M
Average 1.24M
Returns on capital
Ginkgo Bioworks Holdings, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-61.5%
avg -73.4%
ROIC
-30.0%
avg -49.9%
ROA
-27.9%
avg -46.9%
Analysis
ROA is currently the strongest return metric at -27.9% versus its period average of -46.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Steven Coen | Chief Financial Officer | USD 438.69K | 60 | — | — |
Reshma Shetty | Co-Founder, President & Director | USD 255K | 45 | — | — |
Jason Kelly | Co-Founder, Co-COO, CEO & Director | USD 255K | 45 | — | — |
Brian O'sullivan | Head of Commercial | — | — | — | — |
Daniel Marshall | Senior Manager of Communications & Ownership | — | — | — | — |
Jennifer Wipf | Co-Chief Operating Officer | — | — | — | — |
Karen Tepichin | General Counsel & Secretary | — | — | — | — |
Bartholomew Canton | Co-Founder & CTO | — | — | — | — |
Austin Che | Co-Founder & Head of Strategy | — | — | — | — |
Thomas Knight Jr. | Founder | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
24
$4.95M
Net Transaction Value
−$4.95M
Net selling
Most Active
Coen Steven P.
10 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Oct 19, 26Oct 19, 2026 | Canton Barry Indirect | Sell | $226.9K$226,888.77 |
| Oct 19, 26Oct 19, 2026 | Shetty Reshma P. Indirect | Sell | $190.7K$190,718.83 |
| Oct 19, 26Oct 19, 2026 | Canton Barry Direct | Sell | $190.7K$190,718.83 |
| Oct 19, 26Oct 19, 2026 | Shetty Reshma P. Direct | Sell | $226.9K$226,888.77 |
| Oct 19, 26Oct 19, 2026 | Kelly Jason R Direct | Sell | $463.4K$463,352.53 |
| Oct 19, 26Oct 19, 2026 | Coen Steven P. Direct | Sell | $7.8K$7,769.54 |
| Oct 5, 26Oct 5, 2026 | Coen Steven P. Direct | Sell | $36K$36,045.00 |
| Sep 15, 26Sep 15, 2026 | HENRY CHRISTIAN O Direct | Sell | $35.4K$35,405.00 |
| Aug 24, 26Aug 24, 2026 | Coen Steven P. Direct | Sell | $2.3K$2,302.41 |
| Jul 17, 26Jul 17, 2026 | Coen Steven P. Direct | Sell | $5.9K$5,943.06 |
1–10 of 24
Summary
Insiders reported 0 buys worth $0.00 and 24 sells worth $4.95M over the last 12 months. That adds up to net selling of $4.95M. Coen Steven P. was the most active insider with 10 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -29.1% | +21.4% (4yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -29.1% over three years. Forward estimates point to Revenue at +21.4% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Ginkgo Bioworks Holdings, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about DNA's management, answered from reported figures.
Who manages DNA?
Ginkgo Bioworks Holdings, Inc. (DNA) lists 10 active executives. The top listed executive is Reshma Shetty, Co-Founder, President & Director.
Are DNA insiders buying or selling?
Recent insider activity shows net selling of $3.74M.
Continue the stock analysis
Jump to another research area for this company.